Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: 52-week, Double Blind, Randomized, 2 Active Parallel Arms Study of Fixed Combination CHF 5993 Administered vs Ultibro® in COPD Patients
Brief Summary: The aim of the present study is to evaluate the superiority of the fixed triple therapy with BDP/FF/GB at a daily dose of 400/24/50 mcg respectively with that of Ultibro® Breezhaler® (DPI), fixed combination of indacaterol 85 mcg and of glycopyrronium 43 mcg in COPD patients.


Options:
A: Arm Label: BGF MDI (PT010) 320/14.4/9.6 μg ex-actuator; Type: EXPERIMENTAL; Interventions: Drug: BGF MDI 320/14.4/9.6 μg | Arm Label: GFF MDI (PT003) 14.4/9.6 μg ex-actuator; Type: EXPERIMENTAL; Interventions: Drug: GFF MDI (PT003) 14.4/9.6 μg | Arm Label: BFF MDI (PT009) 320/9.6 μg ex-actuator; Type: EXPERIMENTAL; Interventions: Drug: BFF MDI (PT009) 320/9.6 μg | Arm Label: Symbicort; Type: ACTIVE_COMPARATOR; Interventions: Drug: Symbicort® Turbuhaler® (TBH) Inhalation Powder | Intervention Type: DRUG; Name: BGF MDI 320/14.4/9.6 μg; Assigned to Arm(s): BGF MDI (PT010) 320/14.4/9.6 μg ex-actuator | Intervention Type: DRUG; Name: GFF MDI (PT003) 14.4/9.6 μg; Assigned to Arm(s): GFF MDI (PT003) 14.4/9.6 μg ex-actuator | Intervention Type: DRUG; Name: BFF MDI (PT009) 320/9.6 μg; Assigned to Arm(s): BFF MDI (PT009) 320/9.6 μg ex-actuator | Intervention Type: DRUG; Name: Symbicort® Turbuhaler® (TBH) Inhalation Powder; Assigned to Arm(s): Symbicort
B: Arm Label: CHF 5993 + Ultibro matched placebo; Type: EXPERIMENTAL; Interventions: Drug: CHF 5993 + Ultibro matched placebo, Procedure: Central spirometry, Other: COPD assessment test, Procedure: Local laboratory Assessments, Other: Saint George's Respiratory Questionnaire, Other: EXACT-pro questionnaire | Arm Label: Ultibro + CHF 5993 matched placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ultibro + CHF 5993 matched placebo, Procedure: Central spirometry, Other: COPD assessment test, Procedure: Local laboratory Assessments, Other: Saint George's Respiratory Questionnaire, Other: EXACT-pro questionnaire | Intervention Type: DRUG; Name: CHF 5993 + Ultibro matched placebo; Assigned to Arm(s): CHF 5993 + Ultibro matched placebo | Intervention Type: DRUG; Name: Ultibro + CHF 5993 matched placebo; Assigned to Arm(s): Ultibro + CHF 5993 matched placebo | Intervention Type: PROCEDURE; Name: Central spirometry; Assigned to Arm(s): CHF 5993 + Ultibro matched placebo, Ultibro + CHF 5993 matched placebo | Intervention Type: OTHER; Name: COPD assessment test; Assigned to Arm(s): CHF 5993 + Ultibro matched placebo, Ultibro + CHF 5993 matched placebo | Intervention Type: PROCEDURE; Name: Local laboratory Assessments; Assigned to Arm(s): CHF 5993 + Ultibro matched placebo, Ultibro + CHF 5993 matched placebo | Intervention Type: OTHER; Name: Saint George's Respiratory Questionnaire; Assigned to Arm(s): CHF 5993 + Ultibro matched placebo, Ultibro + CHF 5993 matched placebo | Intervention Type: OTHER; Name: EXACT-pro questionnaire; Assigned to Arm(s): CHF 5993 + Ultibro matched placebo, Ultibro + CHF 5993 matched placebo
C: Arm Label: Beclometasone/Formoterol/Glycopyrrolate; Type: EXPERIMENTAL; Interventions: Drug: Beclometasone/Formoterol/Glycopyrrolate | Arm Label: Beclometasone/Formoterol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Beclometasone/Formoterol | Intervention Type: DRUG; Name: Beclometasone/Formoterol/Glycopyrrolate; Assigned to Arm(s): Beclometasone/Formoterol/Glycopyrrolate | Intervention Type: DRUG; Name: Beclometasone/Formoterol; Assigned to Arm(s): Beclometasone/Formoterol
D: Arm Label: fluticasone high dose; Type: EXPERIMENTAL; Interventions: Drug: tiotropium inhalation, Drug: salmeterol xinafoate, Drug: fluticasone propionate | Arm Label: fluticasone medium & low doses; Type: EXPERIMENTAL; Interventions: Drug: tiotropium inhalation, Drug: salmeterol xinafoate, Drug: fluticasone propionate, Drug: placebo matched for fluticasone propionate | Intervention Type: DRUG; Name: tiotropium inhalation; Assigned to Arm(s): fluticasone high dose, fluticasone medium & low doses | Intervention Type: DRUG; Name: salmeterol xinafoate; Assigned to Arm(s): fluticasone high dose, fluticasone medium & low doses | Intervention Type: DRUG; Name: fluticasone propionate; Assigned to Arm(s): fluticasone high dose, fluticasone medium & low doses | Intervention Type: DRUG; Name: placebo matched for fluticasone propionate; Assigned to Arm(s): fluticasone medium & low doses

Answer: B